Diligence memo · auto-generated · as of July 3, 2026
Oncology Institute, Inc.
Oncology Institute, Inc. has raised $126M over 2 rounds; too few niche peers to rank its valuation yet.
Businessfiled
Oncology Institute, Inc. operates in Hospitals and Physicians, based in CERRITOS.
Sub-sector tags: pharma.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Oncology Institute, Inc. has raised $126M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series D+ (a $100M–$400M round).
Largest single filing: $110M on 2022-08-09.
Most recent recorded round closed around 2025-03-26.
Valuation (modeled)modeled
Provath models Oncology Institute, Inc. at approximately $145M (range $91M–$185M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Too few comparable companies in this niche to rank the valuation fairly yet.
Financing rhythm & timingmixed
Historic cadence: a new round about every 32 months.
Last raise 15 mo ago; this sector typically re-raises about every 12 months.
Slightly overdue versus sector cadence.
The last round was 6.7× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 97% of Hospitals and Physicians peers (599 compared).
Modeled value ranks above 87% of those peers.
Peoplefiled
15 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.